TY - JOUR
T1 - Intravenous Phenytoin (Concluded)
AU - Bauman, Jerry L.
AU - Siepler, John K.
AU - Schondelmeyer, Stephen
AU - Gatlin, Larry
AU - Gwilt, Peter
PY - 1977/1/13
Y1 - 1977/1/13
N2 - To the Editor: In a recent issue of the Journal,1 Greenblatt and Shader report their experience with phenytoin addition to 5 per cent dextrose in water for intravenous infusion. We agree entirely that no gross visualization of phenytoin crystals is usually possible when solutions are left standing for eight hours and less. However, to assess the presence of nonvisible crystals in such solutions, the following procedure was undertaken. Parke, Davis intravenous phenytoin, 500 mg, was injected into 500 ml of Baxter Viaflex 5 per cent dextrose in water and dripped over periods of one and four hours. The.
AB - To the Editor: In a recent issue of the Journal,1 Greenblatt and Shader report their experience with phenytoin addition to 5 per cent dextrose in water for intravenous infusion. We agree entirely that no gross visualization of phenytoin crystals is usually possible when solutions are left standing for eight hours and less. However, to assess the presence of nonvisible crystals in such solutions, the following procedure was undertaken. Parke, Davis intravenous phenytoin, 500 mg, was injected into 500 ml of Baxter Viaflex 5 per cent dextrose in water and dripped over periods of one and four hours. The.
UR - http://www.scopus.com/inward/record.url?scp=0017773367&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0017773367&partnerID=8YFLogxK
U2 - 10.1056/NEJM197701132960221
DO - 10.1056/NEJM197701132960221
M3 - Letter
C2 - 830292
AN - SCOPUS:0017596659
SN - 0028-4793
VL - 296
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 2
ER -